Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 7

13 January 2026

Primary Health Properties – Trading Update & Notice of Interim Dividend

Primary Health Properties PLC (“PHP”, the “Group” or the “Company”) Trading update & notice of interim dividend Company’s 30th anniversary of consecutive dividend growth Primary…

13 January 2026

LondonMetric Acquires £89m of Premier Inn Hotels

LONDONMETRIC PROPERTY PLC LONDONMETRIC ACQUIRES £89 million OF PREMIER INN HOTELS LondonMetric Property Plc (“LondonMetric”) announces the acquisition of a further nine Premier Inn hotels for…

8 January 2026

Greggs – Q4 Trading Update

GREGGS PLC (“Greggs” or the “Company”) Q4 TRADING UPDATE OUTPERFORMING A TOUGH MARKET Q4 highlights * Like-for-like (LFL) company-managed shop sales performance against comparable…

7 January 2026

HG Announces An Investment in OneStream

Hg, the Manager of HgCapital Trust plc (“HgT”), today announces an investment in OneStream, Inc. (Nasdaq: OS). The terms of the transaction are not…

7 January 2026

GSK’s Shingrix Receives European Commission Approval

GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved by the European Commission GSK plc (LSE/NYSE: GSK) today announced the European Commission’s (EC) approval of Shingrix (GSK’s Recombinant…

7 January 2026

GSK Release Bepirovirsen Update

GSK announces positive results from B-Well 1 and B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B GSK…

6 January 2026

GSK Announce Exdensur Update

Exdensur (depemokimab) approved in Japan for severe asthma and chronic rhinosinusitis with nasal polyps GSK plc (LSE/NYSE: GSK) today announced the approval of Exdensur (depemokimab) by Japan’s Ministry…

6 January 2026

Prudential Announce $1.2bn Share Buyback

Prudential announces launch of USD 1.2 billion share buyback programme Prudential plc (the “Company”) announces that it will commence a buyback programme of its…

Posts navigation

  • «
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 899
  • »

Home > Market News > Page 7

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG